Transcat (TRNS) Projected to Announce Earnings on Tuesday

Transcat (NASDAQ:TRNS) is expected to be issuing its Q2 2027 results after the market closes on Tuesday, November 3rd. Analysts expect Transcat to announce earnings of $0.4475 per share and revenue of $92.43 million for the quarter. Investors can check the company’s upcoming Q2 2027 earnings report page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 4:30 PM ET.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Transcat had a net margin of 0.99% and a return on equity of 5.56%. The firm had revenue of $92.95 million for the quarter, compared to the consensus estimate of $86.55 million. On average, analysts expect Transcat to post $1.74 EPS for the current fiscal year and $1.92 EPS for the next fiscal year.

Transcat Trading Up 1.7%

NASDAQ TRNS opened at $83.33 on Tuesday. The company has a market capitalization of $782.47 million, a price-to-earnings ratio of 225.22 and a beta of 0.66. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.49 and a quick ratio of 2.11. Transcat has a 12 month low of $50.23 and a 12 month high of $100.00. The company’s fifty day moving average price is $86.46 and its two-hundred day moving average price is $81.10.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a research note on Tuesday, August 25th. Northland Securities raised Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 price target on the stock in a research report on Wednesday, October 21st. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $95.00.

Insider Transactions at Transcat

In other news, Director Christopher P. Gillette sold 504 shares of Transcat stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $94.23, for a total value of $47,491.92. Following the completion of the transaction, the director directly owned 200 shares of the company’s stock, valued at approximately $18,846. The trade was a 71.59% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Craig Cairns purchased 1,050 shares of the firm’s stock in a transaction dated Thursday, August 6th. The stock was acquired at an average cost of $93.97 per share, with a total value of $98,668.50. Following the completion of the acquisition, the director directly owned 1,480 shares in the company, valued at approximately $139,075.60. This trade represents a 244.19% increase in their position. The disclosure for this purchase is available in the SEC filing. Company insiders own 1.80% of the company’s stock.

About Transcat

Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.